Amicus Therapeutics, Inc.
US ˙ NasdaqGM ˙ US03152W1099
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

SecurityFOLD / Amicus Therapeutics, Inc.
InstitutionBarclays Plc
Latest Disclosed Ownership17,755,672 shares
Ownership 5.65%
Barclays Plc ownership in FOLD / Amicus Therapeutics, Inc.

2026-05-14 - Barclays Plc has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 17,755,672 shares of Amicus Therapeutics, Inc. (US:FOLD). This represents 5.65 percent ownership of the company.

Barclays Plc has a history of taking positions in derivatives of the underlying security (FOLD) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date
Effective
Date
Form Prev
Shares
Latest
Shares
ΔShares
(Percent)
Ownership
(Percent)
ΔOwnership
(Percent)
2026-05-14 2026-05-14 13G 17,755,672 5.65

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

FOLD / Amicus Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F AMICUS THERAPEUTICS COM 03152W109 1,134,639 165,117 17.03 16,157 111.51 0.0039
2026-03-31 2025-09-30 13F/A-3 AMICUS THERAPEUTICS COM 03152W109 969,522 -213,213 -18.03 7,640 12.72 0.0017
2026-03-19 2025-09-30 13F/A-2 AMICUS THERAPEUTICS COM 03152W109 631,705 -551,030 6,747 0.0018
2025-11-12 2025-09-30 13F AMICUS THERAPEUTICS COM 03152W109 969,522 -213,213 7,640 0.0017
2026-02-27 2025-06-30 13F/A-2 AMICUS THERAPEUTICS COM 03152W109 1,182,735 546,637 85.94 6,777 30.58 0.0016
2025-08-14 2025-06-30 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 1,182,735 546,637 7 0.0016
2025-08-13 2025-06-30 13F AMICUS THERAPEUTICS COM 03152W109 1,182,735 546,637 7 0.0005
2026-03-17 2025-03-31 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 636,098 -28,562 -4.30 5,191 -17.11 0.0015
2025-05-15 2025-03-31 13F AMICUS THERAPEUTICS COM 03152W109 636,098 -28,562 5 0.0015
2026-03-19 2024-12-31 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 664,660 32,955 5.22 6,261 -7.19 0.0018
2025-02-13 2024-12-31 13F AMICUS THERAPEUTICS COM 03152W109 664,660 32,955 6 0.0018
2026-03-31 2024-09-30 13F/A-2 AMICUS THERAPEUTICS COM 03152W109 631,705 185,314 41.51 6,747 52.35 0.0018
2024-11-19 2024-09-30 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 631,705 185,314 7 0.0018
2024-11-15 2024-09-30 13F AMICUS THERAPEUTICS COM 03152W109 631,705 185,314 7 0.0005
2026-03-23 2024-06-30 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 446,391 97,454 27.93 4,428 7.74 0.0014
2024-08-14 2024-06-30 13F AMICUS THERAPEUTICS COM 03152W109 446,391 97,454 4 0.0014
2026-03-24 2024-03-31 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 348,937 -378,838 -52.05 4,110 -60.20 0.0014
2024-05-15 2024-03-31 13F AMICUS THERAPEUTICS COM 03152W109 348,937 -378,838 4 0.0014
2026-03-25 2023-12-31 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 727,775 315,339 76.46 10,327 105.92 0.0038
2024-02-15 2023-12-31 13F AMICUS THERAPEUTICS COM 03152W109 727,775 315,339 10 0.0038
2026-03-26 2023-09-30 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 412,436 7,096 1.75 5,015 -1.49 0.0031
2023-11-07 2023-09-30 13F AMICUS THERAPEUTICS COM 03152W109 412,436 7,096 5 0.0031
2026-03-30 2023-06-30 13F/A-2 AMICUS THERAPEUTICS COM 03152W109 405,340 -51,810 -11.33 5,091 0.43 0.0032
2023-09-20 2023-06-30 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 405,340 -51,810 5 0.0032
2023-08-03 2023-06-30 13F AMICUS THERAPEUTICS COM 03152W109 405,340 -51,810 5 0.0032
2026-03-30 2023-03-31 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 457,150 35,330 8.38 5,070 -1.57 0.0023
2023-05-04 2023-03-31 13F AMICUS THERAPEUTICS COM 03152W109 457,150 35,330 5 0.0023
2026-03-30 2022-12-31 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 421,820 16,299 4.02 5,150 21.66 0.0023
2023-02-13 2022-12-31 13F AMICUS THERAPEUTICS COM 03152W109 421,820 16,299 5 0.0023
2022-11-03 2022-09-30 13F AMICUS THERAPEUTICS COM 03152W109 405,521 387,185 2,111.61 4,233 2,048.73 0.0046
2022-08-12 2022-06-30 13F AMICUS THERAPEUTICS COM 03152W109 18,336 -88,882 -82.90 197 -80.59 0.0001
2022-05-16 2022-03-31 13F AMICUS THERAPEUTICS COM 03152W109 107,218 -219,041 -67.14 1,015 -73.07 0.0008
2022-02-23 2021-12-31 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 326,259 -125,879 -27.84 3,769 -12.69 0.0014
2022-02-14 2021-12-31 13F AMICUS THERAPEUTICS COM 03152W109 326,259 -125,879 3,769 0.0004
2021-11-09 2021-09-30 13F AMICUS THERAPEUTICS COM 03152W109 452,138 228,331 102.02 4,317 100.05 0.0019
2021-08-13 2021-06-30 13F AMICUS THERAPEUTICS COM 03152W109 223,807 -207,946 -48.16 2,158 -49.41 0.0010
2021-05-13 2021-03-31 13F AMICUS THERAPEUTICS COM 03152W109 431,753 229,812 113.80 4,266 -8.51 0.0023
2021-02-11 2020-12-31 13F AMICUS THERAPEUTICS COM 03152W109 201,941 -238,687 -54.17 4,663 -25.04 0.0025
2020-11-12 2020-09-30 13F AMICUS THERAPEUTICS COM 03152W109 440,628 -38,757 -8.08 6,221 -13.93 0.0037
2020-08-12 2020-06-30 13F AMICUS THERAPEUTICS COM 03152W109 479,385 -81,956 -14.60 7,228 39.35 0.0056
2020-05-13 2020-03-31 13F AMICUS THERAPEUTICS COM 03152W109 561,341 -162,566 -22.46 5,187 -26.43 0.0041
2020-02-10 2019-12-31 13F AMICUS THERAPEUTICS COM 03152W109 723,907 497,092 219.16 7,050 287.58 0.0039
2019-11-15 2019-09-30 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 226,815 77,517 51.92 1,819 -2.36 0.0011
2019-11-14 2019-09-30 13F AMICUS THERAPEUTICS COM 03152W109 226,815 77,517 1,819 420.5549
2019-08-14 2019-06-30 13F AMICUS THERAPEUTICS COM 03152W109 149,298 65,611 78.40 1,863 63.56 0.0011
2019-05-15 2019-03-31 13F AMICUS THERAPEUTICS COM 03152W109 83,687 59,341 243.74 1,139 388.84 0.0008
2019-02-14 2018-12-31 13F AMICUS THERAPEUTICS COM 03152W109 24,346 -75,368 -75.58 233 -80.66 0.0002
2018-11-14 2018-09-30 13F AMICUS THERAPEUTICS COM 03152W109 99,714 85,854 619.44 1,205 457.87 0.0008
2018-08-14 2018-06-30 13F AMICUS THERAPEUTICS COM 03152W109 13,860 -32,281 -69.96 216 -68.83 0.0002
2018-05-15 2018-03-31 13F AMICUS THERAPEUTICS COM 03152W109 46,141 14,135 44.16 693 50.65 0.0005
2018-02-14 2017-12-31 13F AMICUS THERAPEUTICS COM 03152W109 32,006 28,174 735.23 460 693.10 0.0004
2017-11-14 2017-09-30 13F AMICUS THERAPEUTICS COM 03152W109 3,832 -6,564 -63.14 58 -44.76 0.0001
2017-08-14 2017-06-30 13F AMICUS THERAPEUTICS COM 03152W109 10,396 4,323 71.18 105 144.19 0.0001
2017-05-15 2017-03-31 13F AMICUS THERAPEUTICS COM 03152W109 6,073 -217,699 -97.29 43 -96.13 0.0000
2017-02-14 2016-12-31 13F AMICUS THERAPEUTICS COM 03152W109 223,772 86,404 62.90 1,112 9.45 0.0012
2016-11-14 2016-09-30 13F AMICUS THERAPEUTICS COM 03152W109 137,368 137,368 0.00 1,016 0.0011
2016-08-12 2016-06-30 13F AMICUS THERAPEUTICS COM 03152W109 0 -1,175 -100.00 0 -100.00
2016-05-16 2016-03-31 13F AMICUS THERAPEUTICS COM 03152W109 1,175 -15,856 -93.10 9 -94.12 0.0000
2016-02-12 2015-12-31 13F AMICUS THERAPEUTICS COM 03152W109 17,031 -15,919 -48.31 153 -64.34 0.0002
2015-11-13 2015-09-30 13F AMICUS THERAPEUTICS COM 03152W109 32,950 31,053 1,636.95 429 1,488.89 0.0005
2015-08-14 2015-06-30 13F AMICUS THERAPEUTICS COM 03152W109 1,897 783 70.29 27 145.45 0.0000
2015-05-19 2015-03-31 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 1,114 410 58.24 11 83.33 0.0000
2015-05-14 2015-03-31 13F AMICUS THERAPEUTICS COM 03152W109 1,114 11
2015-02-13 2014-12-31 13F AMICUS THERAPEUTICS COM 03152W109 704 563 399.29 6 500.00 0.0000
2014-11-14 2014-09-30 13F AMICUS THERAPEUTICS COM 03152W109 141 -43,191 -99.67 1 -99.23 0.0000
2014-08-14 2014-06-30 13F AMICUS THERAPEUTICS COM 03152W109 43,332 42,019 3,200.23 130 6,400.00 0.0001
2014-05-15 2014-03-31 13F AMICUS THERAPEUTICS COM 03152W109 1,313 516 64.74 2 100.00 0.0000
2014-02-13 2013-12-31 13F AMICUS THERAPEUTICS COM 03152W109 797 -1,346 -62.81 1 -75.00 0.0000
2013-11-14 2013-09-30 13F AMICUS THERAPEUTICS COM 03152W109 2,143 -763 -26.26 4 -42.86 0.0000
2013-08-14 2013-06-30 13F AMICUS THERAPEUTICS COM 03152W109 2,906 2,906 7 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-03-19 2025-09-30 13F/A AMICUS THERAPEUTICS OPT Call 0 0 n/a n/a n/a
2026-03-31 2025-09-30 13F/A AMICUS THERAPEUTICS OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-11-12 2025-09-30 13F AMICUS THERAPEUTICS OPT Call 0 0 n/a n/a n/a
2025-08-14 2025-06-30 13F/A AMICUS THERAPEUTICS OPT Call 32,400 0 n/a n/a n/a
2026-02-27 2025-06-30 13F/A AMICUS THERAPEUTICS OPT Call 32,400 0.00 186 -29.92 n/a n/a n/a
2026-03-17 2025-03-31 13F/A AMICUS THERAPEUTICS OPT Call 32,400 264 n/a n/a n/a
2025-05-15 2025-03-31 13F AMICUS THERAPEUTICS OPT Call 32,400 0 n/a n/a n/a
2024-11-19 2024-09-30 13F/A AMICUS THERAPEUTICS OPT Call 0 0 n/a n/a n/a
2026-03-31 2024-09-30 13F/A AMICUS THERAPEUTICS OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-11-15 2024-09-30 13F AMICUS THERAPEUTICS OPT Call 0 0 n/a n/a n/a
2026-03-23 2024-06-30 13F/A AMICUS THERAPEUTICS OPT Call 114,000 1,131 n/a n/a n/a
2024-08-14 2024-06-30 13F AMICUS THERAPEUTICS OPT Call 114,000 1 n/a n/a n/a
2021-08-13 2021-06-30 13F AMICUS THERAPEUTICS OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-05-13 2021-03-31 13F AMICUS THERAPEUTICS OPT Call 300 3 n/a n/a n/a
2019-11-15 2019-09-30 13F/A AMICUS THERAPEUTICS OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-08-14 2019-06-30 13F AMICUS THERAPEUTICS OPT Call 89,000 1,111 n/a n/a n/a
2018-11-14 2018-09-30 13F AMICUS THERAPEUTICS OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-08-14 2018-06-30 13F AMICUS THERAPEUTICS OPT Call 8,500 133 n/a n/a n/a
2018-02-14 2017-12-31 13F AMICUS THERAPEUTICS OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-11-14 2017-09-30 13F AMICUS THERAPEUTICS OPT Call 115,400 1,740 n/a n/a n/a
2017-05-15 2017-03-31 13F AMICUS THERAPEUTICS OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-02-14 2016-12-31 13F AMICUS THERAPEUTICS OPT Call 67,500 0.00 335 -33.00 n/a n/a n/a
2016-11-14 2016-09-30 13F AMICUS THERAPEUTICS OPT Call 67,500 500 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-13 2025-12-31 13F AMICUS THERAPEUTICS OPT Put 0 -100.00 0 -100.00 n/a n/a n/a
2026-03-19 2025-09-30 13F/A AMICUS THERAPEUTICS OPT Put 114,000 1,218 n/a n/a n/a
2026-03-31 2025-09-30 13F/A AMICUS THERAPEUTICS OPT Put 114,000 0.00 898 37.52 n/a n/a n/a
2025-11-12 2025-09-30 13F AMICUS THERAPEUTICS OPT Put 114,000 898 n/a n/a n/a
2025-08-14 2025-06-30 13F/A AMICUS THERAPEUTICS OPT Put 114,000 1 n/a n/a n/a
2026-02-27 2025-06-30 13F/A AMICUS THERAPEUTICS OPT Put 114,000 -22.13 653 -45.31 n/a n/a n/a
2026-03-17 2025-03-31 13F/A AMICUS THERAPEUTICS OPT Put 146,400 28.42 1,195 11.28 n/a n/a n/a
2025-05-15 2025-03-31 13F AMICUS THERAPEUTICS OPT Put 146,400 1 n/a n/a n/a
2026-03-19 2024-12-31 13F/A AMICUS THERAPEUTICS OPT Put 114,000 0.00 1,074 -11.83 n/a n/a n/a
2025-02-13 2024-12-31 13F AMICUS THERAPEUTICS OPT Put 114,000 1 n/a n/a n/a
2024-11-19 2024-09-30 13F/A AMICUS THERAPEUTICS OPT Put 114,000 1 n/a n/a n/a
2026-03-31 2024-09-30 13F/A AMICUS THERAPEUTICS OPT Put 114,000 1,218 n/a n/a n/a
2024-11-15 2024-09-30 13F AMICUS THERAPEUTICS OPT Put 114,000 1 n/a n/a n/a
2026-03-23 2024-06-30 13F/A AMICUS THERAPEUTICS OPT Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-08-14 2024-06-30 13F AMICUS THERAPEUTICS OPT Put 0 0 n/a n/a n/a
2026-03-24 2024-03-31 13F/A AMICUS THERAPEUTICS OPT Put 84,800 999 n/a n/a n/a
2024-05-15 2024-03-31 13F AMICUS THERAPEUTICS OPT Put 84,800 1 n/a n/a n/a
2021-05-13 2021-03-31 13F AMICUS THERAPEUTICS OPT Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-11 2020-12-31 13F AMICUS THERAPEUTICS OPT Put 276,500 6,384 n/a n/a n/a
2018-02-14 2017-12-31 13F AMICUS THERAPEUTICS OPT Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-11-14 2017-09-30 13F AMICUS THERAPEUTICS OPT Put 46,800 706 n/a n/a n/a
2016-08-12 2016-06-30 13F AMICUS THERAPEUTICS OPT Put 0 -100.00 0 -100.00 n/a n/a n/a
2016-05-16 2016-03-31 13F AMICUS THERAPEUTICS OPT Put 88,000 704 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.